A Novel Ingestible Intraluminal Gastrointestinal Stimulation Capsule System for Treatment of Obesity - First in Human Study

(1) Columbia University,New York,United States

(2) Meir Medical Center,Kfar Saba,Israel

(3) Melcap Systems,Haifa,Israel

This item was part of the Late breaking abstracts: From eosinophilic oesophagitis to novel obesity therapies (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019